NEWS & MEDIA

GLOBES

GLOBES

12 MARCH 2018

Accelemd’s Cogentix Medical aquired by Laborie for $242M

Read more

CISION PR NEWSWIRE

CISION PR NEWSWIRE

12 MARCH 2018

Cogentix Medical Enters Definitive Merger Agreement to be Acquired by Laborie Medical Technologies for a Purchase Price of $3.85 Per Share in Cash

Read more

NASDAQ GLOBE NEWSWIRE

NASDAQ GLOBE NEWSWIRE

05 FEBRUARY 2018

Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more

GLOBES

GLOBES

1 FEBRUARY 2018

Sol-Gel raises $75M

Read more

GLOBES

GLOBES

8 JANUARY 2018

Ladenburg Thalmann Financial Services initiated coverage on shares of Urogen Pharma

Read more

NASDAQ GLOBE NEWSWIRE

NASDAQ GLOBE NEWSWIRE

5 JANUARY 2018

Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

Read more

CALCALIST

CALCALIST

05 JANUARY 2018

Arkin Bioventures’ Censa Pharmaceuticals raised $10M as part of a strategic long-term agreement with Retrophin

Read more

CALCALIST

CALCALIST

28 DECEMBER 2017

Merck, China’s WuXi AppTec and Mori Arkin to Launch Biotech Incubator in Israel

Read more

YAHOO FINANCE

YAHOO FINANCE

14 DECEMBER 2017

BioSight Announces Phase I/II Results of its Cytarabine Pro-Drug BST-236 for Treatment of Acute Leukemia

Read more

GLOBES

GLOBES

7 MAY 2017

Urogen,Israeli urological cancer treatment developer raised 20% more than planned in Nasdaq IPO

Read more

CALCALIST

CALCALIST

5 MAY 2017

Urogen Pharma rasise $58M in Nasdaq IPO

Read more

GLOBES

GLOBES

19 JUNE 2016

Arkin & Phoenix set up $60m biomed investment fund

Read more

PR NEWSWIRE

PR NEWSWIRE

16 MAY 2016

Arkin Holdings and Primera Capital Lead an Investment of $13M in BioSight for an Innovative Treatment of Acute Leukemia

Read more

THE PE HUB NETWORK

THE PE HUB NETWORK

12 APRIL 2016

Israel’s Metabomed raises $18 mln for cancer-metabolism drugs

Read more

FORBES

FORBES

4 JANUARY 2016

Mori Arkin personal history on Forbes 2015 billionaire rankings

Read more

GLOBES

GLOBES

3 JANUARY 2016

Israeli shareholder Arkin rejects Mylan Perrigo bid

Read more

EQUILAR ATLAS

EQUILAR ATLAS

15 SEPTEMBER 2015

Moshe Arkin, Former Board Member at PERRIGO, bibliography

Read more

REUTERS

REUTERS

10 SEPTEMBER 2015

Israeli Perrigo shareholder slams Mylan’s $27 billion offer

Read more

GLOBES

GLOBES

28 JULY 2015

Merck buys cCAM Biotherapeutics for up to $605m

Read more

BIOSPACE

BIOSPACE

1 JUNE 2015

cCAM Biotherapeutics receives FDA approval to initiate phase One trial for CM-24, a novel immune checkpoint inhibitor for cancer immunotherapy

Read more

GLOBES

GLOBES

17 JULY 2014

Mori Arkin in talks to buy Sol-Gel

Read more

JEWISH BUSINESS NEWS

JEWISH BUSINESS NEWS

14 JULY 2014

Perrigo up for sale

Read more

STREETINSIDER.COM

STREETINSIDER.COM

16 NOVEMBER 2011

Arkin Holdings lowers stake in Perrigo (PRGO) to 5.35%

Read more

PR NEWSWIRE

PR NEWSWIRE

13 SEPTEMBER 2007

Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service

Read more

FINANCIAL TIMES

FINANCIAL TIMES

15 NOVEMBER 2004

Perrigo buys Israel’s Agis for $818m

Read more